Article Figures & Data
Tables
- Table 1.
Demographic Characteristics of Survey Respondents and Self-Reported Frequency of Opioid* Prescribing
Japanese Respondents (n = 435)† US Respondents (n = 198) P Value‡ Sex <.001 Female 70 (16.4) 96 (49.0) Male 358 (83.6) 100 (51.0) Age (years) <.001 <40 184 (43.0) 57 (28.9) 41–50 132 (30.8) 64 (32.5) 51–60 95 (22.2) 54 (27.4) >60 17 (1.0) 22 (11.2) Use opioids to control acute pain§ or chronic pain‖ <.001¶ Never/seldom 105 (24.1) 2 (1.0) Occasionally to all the time 330 (75.9) 196 (99.0) Use opioids to control acute pain <0.001 Never/seldom 220 (50.6) 6 (3.0) Occasionally to all the time 215 (49.4) 192 (97.0) Use opioids to control chronic pain <.001 Never/seldom 158 (36.3) 18 (9.1) Occasionally to all the time 277 (63.7) 180 (90.9) Frequency of opioid use in own country** <.001 Seldom/just right 396 (93.4) 9 (4.6) Too often 28 (6.6) 187 (95.4) Opioids are indicated for chronic pain†† 317 (73.9) 115 (58.7) <.001‡‡ Data are n (%). Totals may vary because some respondents did not complete all parts of the questionnaires.
↵* Opioids include tramadol, codeine, buprenorphine, pentazocine, morphine, fentanyl, methadone, and hydromorphone.
↵† A total of 461 responses were received, but 26 respondents (5.4%) had no opioid prescribing license, leaving 435 prescribers to analyze.
↵‡ P values from a χ2 test unless otherwise specified.
↵§ Acute pain includes acute nonobstructing kidney stones and sprain or strain of any joint.
↵‖ Chronic pain includes chronic nonspecific back pain, osteoarthritis of any joint, fibromyalgia, or other, similar conditions.
↵¶ P value from Fisher exact test because of the small cell size.
↵** Personal belief that opioids are used too seldom/used just right versus opioids are used too often.
↵†† Very strongly/strongly/mildly agree versus neutral/disagree/strongly disagree.
↵‡‡ P values for adjusted odds ratios.
- Table 2.
Physician Self-Report of Factors That Influence Opioid Prescribing for Acute Pain in the United States and Japan
Agree/Strongly Agree, n (%) OR* (95% CI) P Value† Medically indicated Japan 130 (52.6) 1.00 (ref) — United States 168 (86.6) 5.33 (3.15–9.05) <.001 Standard of care 1.00 (ref) Japan 66 (27.3) 4.57 (2.91–7.17) — United States 128 (66.0) <.001 Patient expectation Japan 121 (49.2) 1.00 (ref) — United States 89 (45.9) 0.94 (0.62–1.44) .790 Maintaining patient satisfaction Japan 119 (48.4) 1.00 (ref) — United States 98 (50.8) 1.22 (0.80–1.87) .360 Legal expectation Japan 16 (6.6) 1.00 (ref) — United States 29 (15.1) 2.47 (1.22–5.04) .012 - Table 3.
Self-Report of Factors That Influence Opioid Prescribing for Chronic Pain in the United States and Japan
Agree/Strongly Agree, n (%) OR* (95% CI) P Value† Medically indicated Japan 211 (69.2) 1.00 (ref) — United States 146 (75.6) 1.29 (0.83–2.03) .260 Standard of care Japan 130 (42.9) 1.00 (ref) — United States 107 (56.0) 1.60 (1.07–2.39) .023 Patient expectation Japan 193 (63.1) 1.00 (ref) — United States 109 (56.5) 0.83 (0.55–1.25) .380 Maintaining patient satisfaction Japan 201 (65.3) 1.00 (ref) — United States 103 (53.6) 0.68 (0.45–1.02) .061 Legal expectation Japan 25 (8.6) 1.00 (ref) — United States 33 (17.6) 2.03 (1.09–3.77) .026